Halo 110-101: Early safety results of pegvorhyaluronidase alfa (PEGPH20; PVHA) + cisplatin (C) + gemcitabine (G) ± atezolizumab (ATZ) in patients (pts) with locally advanced or metastatic cholangiocarcinoma (CCA) and gallbladder cancer (GBC) Meeting Abstract
| Authors: | Oh, D. Y.; Muhsin, M.; Bullock, A. J.; Abou-Alfa, G. K.; Shroff, R. T.; Sigal, D.; Chung, V.; Hecht, J. R.; Wu, W.; Borad, M. J. |
| Abstract Title: | Halo 110-101: Early safety results of pegvorhyaluronidase alfa (PEGPH20; PVHA) + cisplatin (C) + gemcitabine (G) ± atezolizumab (ATZ) in patients (pts) with locally advanced or metastatic cholangiocarcinoma (CCA) and gallbladder cancer (GBC) |
| Meeting Title: | 2019 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2019 Jan 17-19 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-02-01 |
| Language: | English |
| ACCESSION: | WOS:000489107600437 |
| DOI: | 10.1200/JCO.2019.37.4_suppl.408 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 408 -- Source: Wos |
